Lb Pharmaceuticals (LBRX) EBIT (2024 - 2026)
Lb Pharmaceuticals' quarterly EBIT came in at -$19.1 million in Q1 2026, down 259.1% year-on-year from $12.0 million in Q1 2025, and down 66.11% quarter-over-quarter from -$11.5 million in Q4 2025.
Lb Pharmaceuticals has reported EBIT for 3 years, with the latest figure at -$19.1 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 259.1% year-over-year to -$19.1 million; the trailing twelve-month figure through Mar 2026 stood at -$39.4 million (changed N/A YoY), and the FY2025 full-year result was -$25.2 million, up 60.06% from the prior year.
- EBIT for Q1 2026 stood at -$19.1 million, down from -$11.5 million in the prior quarter.
- The five-year high for EBIT was -$3.6 million in Q3 2025, with the low at -$19.1 million in Q1 2026.
- Average EBIT over 3 years is -$9.8 million, with a median of -$8.4 million recorded in 2025.
- Year-over-year, EBIT soared 74.92% in 2025 and slumped 259.1% in 2026.
- Tracing LBRX's EBIT over 3 years: stood at -$5.1 million in 2024, then sank by 126.25% to -$11.5 million in 2025, then sank by 66.11% to -$19.1 million in 2026.
- The last three EBIT figures came in at -$19.1 million (Q1 2026), -$11.5 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Lb Pharmaceuticals | 789.92 Mn | 789.92 Mn | - | -19.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.05 Mn |
| Dec 31, 2025 | -11.47 Mn |
| Sep 30, 2025 | -3.56 Mn |
| Mar 31, 2025 | -5.31 Mn |
| Dec 31, 2024 | -5.07 Mn |
| Sep 30, 2024 | -14.18 Mn |